The objective of our study was to determine whether antibiotic pressure in the units of a teaching hospital affects the acquisition of methicillin-resistant Staphylococcus aureus (MRSA), independently of the other collective risk factors previously shown to be involved (MRSA colonization pressure, type of hospitalization unit, and care workload). The average incidence of acquisition of MRSA during the 1-year study period was 0.31 cases per 1000 days of hospitalization, and the use of ineffective antimicrobials reached 504.54 daily defined doses (DDDs) per 1000 days of hospitalization. Univariate analysis showed that acquisition of MRSA was significantly correlated with the use of all antimicrobials, as well as correlated with the use of each class of antimicrobial and with colonization pressure. Multivariate analysis with a Poisson regression model showed that the use of antimicrobials was associated with the incidence of acquisition of MRSA, independently of the other variables studied, but it did not allow us to determine the hierarchy of the different antimicrobial classes with respect to the effect.
strains multiply on the contaminated tissue and may then colonize and possibly infect the patient. This progression to symptomatic infection is promoted by the existence of a site of entry, such as a wound or an indwelling venous or urinary catheter.
Many studies have identified individual risk factors for MRSA infection. These factors can be divided into 3 categories: (1) those related to the number of potential reservoirs and the number of opportunities for crosstransmission, (2) those associated with the immunological status of the patients, and (3) those related to the antibiotics used to treat the patients [7] [8] [9] [10] [11] [12] . These case-control studies only identified associations at the level of individual patients and did not, therefore, take into account the wider picture and the complexity of the problem [13] . Indeed, the use of antimicrobials to treat individuals has an ecological impact on all of the patients hospitalized in the same unit [14] . Only a few studies have taken these collective approaches into account. These studies tend to be fragmented, and they consider the influence of colonization pressure [15] or antibiotic pressure [16] but never both simultaneously. Moreover, these studies also have attempted to determine whether antibiotic pressure was a risk factor for MRSA acquisition by comparing data from different hospitals or by using the data collected in a single type of unit, such as intensive care units [15, 17] . The objective of our study was to determine whether antibiotic pressure within the units of a teaching hospital affects the incidence of acquisition of MRSA, independently of the other collective risk factors previously shown to be involved.
PATIENTS AND METHODS
Setting and study period. The Besançon Hospital (Besançon, France) is a university-affiliated hospital with 1228 acute care beds and is divided into 59 units (35 medical units, 21 surgical units, and 3 intensive care units). Specialty services include cardiothoracic surgery and organ and bone marrow transplantation. Approximately 50,000 inpatients are admitted per year, for a total of 350,000 patient days. Data were collected from 1 October 2000 through 30 September 2001.
MRSA control program. In 1994, our infection control committee made the control of MRSA a major priority. An MRSA-control program was progressively implemented in all high-risk units. Since 1997, 14 of the 59 units (corresponding to all of the high-risk departments, including the adult intensive care units and the septic surgical unit) have been following this program. The control strategy is based on screening nasal fluid samples from all patients for MRSA at the time of admission to the unit. In the first 48 h after admission, before the results of the screening cultures are available, patients are considered to be positive for MRSA and kept in isolation. Patients who are actually positive for MRSA are then given nasally administered mupirocin. All MRSA-positive patients are kept in individual rooms or in cohorts. Special precautions are taken to prevent cross-contamination, including the use of disposable gowns and gloves, the use of an antiseptic soap for hand washing, and the implementation of strict environmental hygiene measures. These procedures are also applied to patients in lowrisk departments (who are not screened at the time of admission to the unit) whose clinical samples test positive for MRSA. The program did not include any restrictions on antibiotic use.
MRSA-positive patients. A patient was classified as being "MRSA positive" if they provided a clinical specimen that tested positive for MRSA during the study period and if the patient was not known to have tested positive for MRSA during the previous 3 years, on the basis of the mean duration of MRSA carriage (figure 1) [18] . MRSA-positive patients were classified as having "imported MRSA carriage" if they tested positive for MRSA within 48 h after admission to the hospital or as having "acquired MRSA carriage" if they tested negative for MRSA during the first 48 h after admission to the hospital. Patients with acquired MRSA carriage were further classified as having "endogenous acquired MRSA carriage" (the NAC group) on the basis of a previous MRSA-positive surveillance culture result, "exogenous acquired MRSA carriage" (the XAC group) on the basis of a previous MRSA-negative surveillance culture result, or "undetermined acquired MRSA carriage" (the UAC group) if there was no surveillance culture result available. The mean duration of hospitalization before acquisition was 18 days for the XAC group, 16 days for the UAC group, and 10 days for the NAC group. The UAC group was combined with the XAC group, and we considered that this combined group contained the correct number of patients with XAC (which we labelled as the "real acquired case" group). This combination was based on the mean delay before acquisition and on the distribution of cases of acquired MRSA carriage within the hospital units participating in the MRSA-control program. Indeed, in this type of unit, the XAC group accounted for 80% of the total number of cases of acquired MRSA carriage. We also combined the imported MRSA carriage group and the NAC group (which we labelled the "real imported case" group). The incidence of MRSA carriage was expressed as cases per 1000 days of hospitalization.
MRSA colonization pressure. The colonization pressure was calculated for each hospital unit as the ratio of the number of MRSA-positive patient-days (whatever the type of specimen [clinical or screening] used to identify MRSA carriage) to the total number of patient-days. Patients previously known to be MRSA positive, patients with MRSA carriage (i.e., patients for whom only the screening culture tested positive for MRSA), and patients in the real imported cases group were considered to have had MRSA carriage throughout their hospital stay. Patients in the real acquired cases group were considered to have had MRSA carriage from the date of obtainment of the sample that tested positive until discharge from the hospital or death. We distinguished 2 types of colonization pressure, according to the nature of the cases of MRSA carriage: "CP1," which labelled the colonization pressure exerted by the patients with real imported cases, the patients with MRSA carriage, and the patients previously known to be MRSA positive; and "CP2," which labelled the colonization pressure exerted by the patients with real acquired cases (figure 1). The colonization pressure values were calculated for each hospital unit and expressed as days per 1000 days of hospitalization.
Antibiotic selective pressure. The quantities of each antimicrobial delivered to each hospitalization unit during the study period were determined from the pharmacy information system. Data on the amounts of antimicrobials used that were expressed in grams and international units were converted to express use as defined daily doses (DDDs), following the recommendations of the World Health Organization [19] . Antimicrobials were grouped into 6 classes: aminoglycosides, b-lactams, fluoroquinolones, glycopeptides, macrolides, and other; the b-lactams were further subdivided into penicillins and cephalosporins. For the analysis, antimicrobials were classed as being effective or ineffective against MRSA. Glycopeptides, gentamicin, rifampicin, pristinamycin, and fusidic acid were considered to be effective. Indeed, 85% of the MRSA isolates displayed the same phenotypic characteristics (susceptibility to antibiotics). All other antimicrobials were considered to be ineffective. Antimicrobial use was finally expressed as the number of DDDs per 1000 patient-days for each unit.
Characterization of hospitalization units and care workload. Data on the number of patient-days for each unit during the study period was obtained from the hospital admission department. The hospital units were classified into 3 types: medicine units ( ), surgery units ( ), and intensive n p 37 n p 19 care units ( ). The units were further divided into 2 groups n p 3 according to whether they participated in the MRSA control program. The nursing workload was assessed according to the nursing care requirements of the Project for Research in Nursing (PRN) [20] . The PRN is a Canadian information system for the management of nursing staff in hospitals; it has been validated [21] . Outside Canada, PRN is used in France, Spain, and the United Kingdom. It estimates the quantity of nursing care required by each patient during a 24-h period. Annual averages were used to quantify the nursing workload for each hospital unit. This program measures the temporal nursing care workload per patient and per 24-h period by computer.
Statistical analysis. The study approach was ecological, focused on the hospitalization units. Thus, the data were all aggregated at this level. Statistical analysis was conducted to explore the relationships between the number of acquired cases of MRSA (expressed as an annual incidence rate) and several variables for each unit: the type of hospital unit (medicine, surgery, or intensive care), participation in the MRSA control program, care workload, antimicrobial pressure exerted by use carriage, the patients with MRSA carriage, and the patients previously known to be MRSA positive ("CP1"; see Methods, "MRSA colonization pressure").
of ineffective antimicrobials, and colonization pressure exerted by imported MRSA carriage (i.e., CP1), which are recognized as potential risk factors for the acquisition of MRSA carriage [15] [16] [17] . In our model, the number of acquired cases of MRSA was directly linked, by construction in our model, to CP2. Thus, we retained CP1 as an indicator of colonization pressure. Furthermore, this choice was supported by the results of previous studies that showed MRSA acquisition is mainly dependent on CP1 [17, 19] . Association between variables and the incidence of MRSA carriage were tested in univariate analysis with the Spearman, Kruskall-Wallis, and Mann-Whitney tests. We retained those variables that seemed to be statistically associated with an incidence of MRSA carriage with a threshold P value of .20. Subsequently, Poisson regression was used in a 2-stage multivariate analysis. First, excluding antimicrobial pressure, a reference model was built by introducing the variables that were found to be significant at in the univariate analysis. P ! .20 Second, antimicrobial variables were separately introduced into the reference model. At this stage, and for each antimicrobial class, the hospitalization units were grouped and classified as "weak consumers" (this was used as the base group), "medium consumers," or "high consumers" of the specified class of antimicrobials; it was assumed that there were an equal number of hospital units in each of the 3 categories. Because of the use of these classifications, no hypotheses have to be made about the relationships between MRSA carriage and antimicrobial pressure, and some statistical relationships could be explored (linear, threshold or plateau effect). Likelihood-ratio tests were used to compare the fit of nested models and to provide a test of significance for the last term added to the model. Use of interaction terms of each significant variable in the final models did not significantly improve the models.
was consid-P р .05 ered to be significant. Analyses were performed with the Systat software (SPSS) and Egret software (Cytel Software), version 2.0.
RESULTS
During the study period, 234 cases of MRSA carriage were identified. Of these 234 cases, 124 were classified as real acquired cases, which corresponds to an annual incidence of 0.31 cases per 1000 days of hospitalization in the entire hospital and to annual incidences ranging from 0.0 to 1.63 cases per 1000 days of hospitalization in the different hospital units. The mean MRSA colonization pressure was 20 days per 1000 days of (table 2) . Results for the derived models, including antimicrobial use, are shown in table 3. Antimicrobial use significantly influenced the rate of acquisition of MRSA. The incidences of acquired MRSA carriage were significantly higher in the medium and high consumer units than in the weak consumer units. Rate ratios ranged from 1.8 to 6.6, depending on the type of consumer and the antimicrobial class (figure 2). The highest risks were observed for b-lactams (especially penicillins) and fluoroquinolones.
DISCUSSION
The findings of this study confirm those of a small number of previous studies that have found a relationship between antimicrobial use and the frequency of MRSA acquisition [16, 22, 23]. It also shows that this relationship persists when MRSA colonization pressure and the type of hospital unit are taken into account, and that it is observed in hospital units other than intensive care units. To date, no studies have demonstrated the effect of antimicrobial use on MRSA spread when considering other identified risk factors, such as MRSA colonization pressure and the type of hospital unit. Moreover, we consider that the incidence of real acquired cases of MRSA carriage is the best indicator to measure the risk of acquiring MRSA. Other indirect indicators, such as frequency of resistance within the species or total cases of acquired MRSA carriage, are less specific.
Three hypotheses can explain the lack of association between MRSA acquisition and the care workload. First, the care workload does not influence the rate of MRSA acquisition. Second, our indicator did not correctly represent the care workload. Third, this indicator is not adequate in our type of study and would be more accurate in another study design.
The literature provides indirect evidence of a relationship between antimicrobial use and the emergence of resistance in hospitals. According to McGowan [24] , this evidence can be divided into 4 categories: (1) evidence of consistent associations, (2) evidence of dose-response effects, (3) evidence of concomitant variation, and (4) evidence from a plausible biological model. A consistent association established at the level of the hospital unit is particularly strong for b-lactams and fluoroquinolones. The positive correlation between evidence for use of these different antimicrobial families is associated with a similar effect on the incidence of MRSA acquisition. This correlation can be explained by the frequent use of antimicrobial combinations for the treatment of bacterial infections and by the fact that our study did not take the effect of time into account, such that data for the different treatments form an indivisible whole. Nevertheless, the stratification of the hospital units into antimicrobial-consumer classes allowed us to eliminate the scale effect of each antimicrobial class from the data for total antimicrobial use and to characterize the impact of high antimicrobial use compared with weak antimicrobial use for each antimicrobial class. Despite our use of this analysis, we could not directly determine a hierarchy among the different antimicrobial classes. The importance of b-lactams and fluoroquinolones that we observed is consistent with the findings of Loulergues et al. [22] , who compared data for different surgical units in a hospital, and those of Crowcroft et al. [16] and Monnet et al. [25] , who performed interhospital comparisons. Crowcroft et al. [16] and Monnet et al. [25] observed a positive correlation between the frequency of resistance among Staphylococcus aureus isolates among the species and antimicrobial use; in the study of Monnet et al. [25] (ICARE project), the correlation was with use of carboxy-or ureido-penicillins, and, in the study of Crowcroft et al. [16] (which was performed in Belgian hospitals), the correlation was with use of ceftazidime, cefsulodin, amoxicillin plus clavulanic acid, and quinolones.
Our study revealed different dose-response effects. Unlike the 2 studies mentioned above [16, 25] , we tested the hypothesis of a linear dose-effect relationship. Given the rate ratios (table  3 and figure 2) , the hypothesis of a linear effect seems to be true for fluoroquinolones and cephalosporins. For the other antimicrobial classes, particularly the penicillins, a plateau effect is more likely [26] .
The third criterion that can be used to establish causality is concomitant variation-that is, an increase in antimicrobial use followed by an increase in resistance. The suspected cause (a change in antimicrobial use) must take place before the effect (a change in the level of antimicrobial resistance). In our study, the MRSA acquisition events were rare, and the study was performed on the scale of the hospital unit; therefore, we had to analyze the relationship on the basis of aggregated yearly data, rather than taking into account the temporal criteria. We plan to improve our analysis by using time series analysis as statistical tool. Unlike classical statistical methods that assume that the observed data are independent random variables, time series analysis takes into account relationships between consecutive observations [26] . This technique was developed by Lopez-Lozano and Monnet and colleagues [23, 27] to investigate the relationship between the emergence of antimicrobial resistance and the use of antimicrobials.
McGowan [24] proposed a biological model to explain the relationship between antimicrobial use and the emergence of resistance. At the level of the individual patient, antimicrobial treatment leads to a large modification in the endogenous flora. The usual result is that susceptible strains are replaced by resistant ones. At the collective level, antimicrobial use in a hospital unit tends to maintain the presence of multidrug-resistant organisms in inpatients, health care workers, and the environment. In cases in which basic infection-control practices are inconsistently applied, these pathogens are implicated in the majority of infections. Antimicrobials such b-lactams and fluoroquinolones, which are ineffective against MRSA and have excellent tissue diffusion, could promote the acquisition of MRSA by increasing the "receptiveness" of the patients and thereby allowing the progression towards colonization and infection.
MRSA acquisition depends on 2 major and independent determinants: colonization pressure and antimicrobial selective pressure. Previous studies have reported that the role of each of these 2 factors may vary depending on the epidemiological situation [28, 29] . In the case of colonization with distinct multiple clones of MRSA, antimicrobial pressure plays the major role; in the case of colonization with a single dominant clone of MRSA, colonization pressure plays a major role. Our results are not consistent with this model. Indeed, in our hospital, 180% of the cases of MRSA colonization/infection are caused by a single clone (data not shown). However, our study demonstrates that the selective pressure caused by use of antimicrobials is an independent risk factor for MRSA acquisition.
Our results are consistent with those of several recent studies that support a causal relationship between antimicrobial use and MRSA acquisition [13, 14, [30] [31] [32] [33] . The dissemination of epidemic clones does not necessarily require antimicrobial selective pressure. However, the results of these recent studies and our results suggest that antimicrobials contribute to MRSA spread. Furthermore, 14 hospitals in countries with very low incidences of MRSA, particularly Nordic countries, use the least amount of antimicrobials in Europe [34] . Additional research is needed to understand fully the relationship between antimicrobial use and MRSA acquisition. However, there is evidence supporting the implementation of programs to control and to improve prescription practices when infection control alone fails to control the spread of MRSA.
